Marizyme

Marizyme FCF per Share

The Free Cash Flow per Share of Marizyme (MRZM) as of Nov 5, 2026 is -0.10 USD. In the previous year, Free Cash Flow per Share was -0.04 USD — a change of 189.83% (lower).

FCF per Share

-0.10USD

YoY

189.83%

Last updated:

Free Cash Flow per Share of Marizyme is 2024 -0.10 USD. Free Cash Flow per Share of Marizyme was 2023 -0.04 USD. It decreases by 189.83% lower compared to the previous year.

The Marizyme FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
0.00 USD
Jan 1, 2018
-0.06 USD
Jan 1, 2019
-0.01 USD
Jan 1, 2020
-0.09 USD
Jan 1, 2021
-0.16 USD
Jan 1, 2022
-0.27 USD
Jan 1, 2023
-0.04 USD
Jan 1, 2024
-0.10 USD
The Marizyme FCF per Share history
YEARFCF per ShareYoY
-0.10USD+189.83%
-0.04USD-86.66%
-0.27USD+67.52%
-0.16USD+69.46%
-0.09USD+1,391.12%
-0.01USD-88.82%
-0.06USD-2,217.25%
0.00USD-98.13%
0.14USD-4,223.84%
-0.00USD-78.88%
-0.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Marizyme Stock analysis

What does Marizyme do? Marizyme Inc. is a biotechnology company focused on the development of enzymes and enzyme products. The company was founded in 2011 and is based in Sarasota, Florida. Marizyme has gained recognition in recent years through innovative technologies, research, and collaboration with leading partners worldwide. Marizyme's business model is centered around the development and commercialization of enzyme products for medical, dermatological, agricultural, and industrial applications. The company has developed a wide range of enzymatic products to address various uses, including enzymes for wound healing, removal of biofilm-based infections, inflammation and impurities, food preservation, cleaning of chemically contaminated groundwater, among others. The company has several divisions, including: 1. Medical Division: Marizyme has developed a wide range of enzymatic products for wound healing, including an innovative hydroactive gel that can remove biofilm-based infections faster and more effectively than conventional methods. 2. Dermatological Division: The company offers enzymatic products for the removal of skin imperfections such as acne, hyperpigmentation, age spots, and melasma. 3. Agricultural Division: Marizyme has also developed enzymatic products for agriculture, including products to enhance the shelf life of fruits and vegetables, improve the quality of dairy products, and combat plant diseases. 4. Industrial Division: The company also offers enzymatic products for industrial cleaning, removal of heavy metals, odor neutralization, and water and soil remediation. Marizyme has an experienced team and close relationships with leading partners worldwide to ensure research and development at the highest level. The company prioritizes quality and safety in its products to achieve the best results for its customers. Overall, Marizyme has taken a strong leadership role in the enzyme industry. The company has developed innovative technologies to utilize enzyme products in a variety of applications for different industries. Marizyme sets high standards for quality and safety of its products and has a bright future ahead. Marizyme is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marizyme stock

Free Cash Flow per Share of Marizyme is -0.10 USD in 2024.

Free Cash Flow per Share of Marizyme changed from -0.04 USD to -0.10 USD, representing a 189.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Marizyme since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Marizyme

All Key Metrics — Marizyme